Market Tracker

05/21 1:09pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

4.51
Delayed Data
As of 12:52pm ET
 -0.0463 / -1.02%
Today’s Change
1.28
Today|||52-Week Range
6.74
+35.14%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close4.56
Today’s open4.56
Day’s range4.46 - 4.70
Volume237,885
Average volume (3 months)576,550
Market cap$151.0M
Data as of 12:52pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)+35.53%
Earnings growth (this year)-22.45%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc0.000.00%
TRILTrillium Therapeutic...-0.15-2.38%
VRMLVermillion Inc+0.03+2.80%
IDXGInterpace Diagnostic...-0.01-1.11%
Data as of 12:50pm ET, 05/21/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$16.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts